Techno Medica Co., Ltd.
6678.T · JPX
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Market Cap | ¥12,152,538 | ¥13,656,603 | ¥15,993,461 | ¥13,259,762 |
| - Cash | ¥9,061,387 | ¥8,586,360 | ¥11,750,289 | ¥11,523,507 |
| + Debt | ¥0 | ¥0 | ¥0 | ¥0 |
| Enterprise Value | ¥3,091,151 | ¥5,070,243 | ¥4,243,172 | ¥1,736,255 |
| Revenue | ¥9,905,864 | ¥10,283,851 | ¥9,367,586 | ¥9,699,077 |
| % Growth | -3.7% | 9.8% | -3.4% | – |
| Gross Profit | ¥4,868,996 | ¥5,152,371 | ¥4,630,294 | ¥4,817,281 |
| % Margin | 49.2% | 50.1% | 49.4% | 49.7% |
| EBITDA | ¥1,419,349 | ¥1,952,000 | ¥1,757,509 | ¥1,952,516 |
| % Margin | 14.3% | 19% | 18.8% | 20.1% |
| Net Income | ¥1,004,583 | ¥1,348,130 | ¥1,150,733 | ¥1,281,384 |
| % Margin | 10.1% | 13.1% | 12.3% | 13.2% |
| EPS Diluted | 145.08 | 172.95 | 136.35 | 150.85 |
| % Growth | -16.1% | 26.8% | -9.6% | – |
| Operating Cash Flow | ¥977,535 | ¥1,142,703 | ¥887,240 | ¥2,062,978 |
| Capital Expenditures | -¥24,866 | -¥102,225 | -¥138,738 | -¥80,171 |
| Free Cash Flow | ¥952,669 | ¥1,040,478 | ¥748,502 | ¥1,982,807 |